ESG in Emerging Markets Equity
How ESG analysis expertise can add value and mitigate risk
Access to information contained on this website is exclusively reserved for professional investors in Luxembourg. Please read the important information below. This contains legal and regulatory information which applies to our company status, use of this website and information about any investment in our products referred to in this website. Note that you will have to accept these terms and conditions before you can proceed. Copyright 2021 by Nordea Investment Funds S.A. – all rights reserved.
Access to information contained on this website is exclusively reserved for investors in Luxembourg. Please read the important information below. This contains legal and regulatory information which applies to our company status, use of this website and information about any investment in our products referred to in this website. Note that you will have to accept these terms and conditions before you can proceed. Copyright 2021 by Nordea Investment Funds S.A. – all rights reserved.
When the celebrity who breaks the record for the greatest number of new Instagram followers is not a Hollywood superstar, but the venerable naturalist, Sir David Attenborough, it’s obvious that environmental awareness isn’t just mainstream – it’s at the very top of global awareness.
Last year was ‘the year of ESG’ according to The Financial Times, with assets in the ‘environmental, social and governance’ (ESG) space reaching a record high of USD 960bn by the end of the year2. This is good news for conscientious investors—particularly those in Emerging Markets (EM), but understanding the field is essential.
Meta research leveraging the results of over 2000 studies in relation to ESG and its impact on the financial performance of companies revealed ESG factors were more important in EM than they were in the developed markets (DM).3 In addition, the likelihood an investor is exposed to severe ESG risks is much higher in EM, where there is less published ESG data. In general, an EM equity investor is exposed to 14.2% more unmanaged ESG risks than a DM investor.4
For EM investors in general, looking at ESG factors makes sense as the market is increasingly recognising responsible investment. In addition to the benefit of risk reduction associated with ESG factors, we are convinced companies that implement ESG practices are more likely to succeed over the long term. As many eyes are now turning to EMs, it is crucial to properly understand and analyse ESG benefit and risk.
As many eyes are now turning to EMs, it is crucial to properly understand and analyse ESG benefit and risk.
Finding strong ESG credentials in emerging markets
The challenge for investors who want to access the myriad opportunities for growth in emerging markets is how to find investments that satisfy the high ESG criteria set in the developed world. Finding ESG-aligned investments in Emerging Markets is undoubtedly difficult. They are both in short supply and highly sought after. And the danger of making uninformed and risky investments in these markets is high. No investor wants to be involved with a company like Boohoo, a UK-based fashion retailer which was investigated after a scandal broke about working conditions at its factories. The company’s shares plummeted by GBP 1bn amid claims of poor pay and working conditions. Major retailers and investors were quick to distance themselves. The possibilities for making the wrong investment decision abound from companies involved with unethical labour practices, ecological disasters, pollution, blood diamonds, and other ethics violations.
Robust ESG legislation has yet to be put in place in many developing countries where there is also a vast dispersion of ESG practices and a relative lack of reporting. Hence, often the only way to find out if a company has good enough ESG credentials to be a viable investment is for an asset manager to have an in-house team of experts able to conduct extensive analysis before investing.
Meeting ESG challenges head on
At Nordea Asset Management (NAM), we believe that more sustainable companies will find both opportunities and risk reduction arising from their treatment of ESG issues, and this is reflected in our valuation. We specifically take our internal ESG scoring into consideration when we value a business, so that a more sustainable business will enjoy a higher valuation of its current earnings and a better trajectory for its future earnings. Intuitively, this makes sense but our methodology ensures it is applied consistently across our ESG STARS strategies.
We’re focused on evaluating companies holistically: looking for growth potential, competitive advantages, a strong return profile, and the material ESG risks and opportunities. Our forward looking approach to scoring companies assesses how we can get involved, if necessary, to strengthen the ESG credentials before or during investment. We also assess how sustainability trends can positively or negatively impact the company’s business model, its value chain, products and services. In short, what we really want to find out is – does this business have a great and sustainable future ahead?
Our Emerging Stars Equity Strategy is at the forefront of fully integrating ESG considerations into fundamental analysis – from idea generation to valuation. Portfolio managers work closely with our inhouse Responsible Investments Team to synthesize fundamental analysis and ESG research. We have embedded in each strategy’s investment team a dedicated ESG specialist. Our ESG analysts are there every step of the way through the investment process – participating in daily and weekly meetings, as well as in idea generation and case presentations.
Ping An: A Good Doctor
To find the very best companies for our ESG STARS strategies, Nordea Asset Management not only looks at the fundamentals, but also engages with companies on ESG topics that can be of material risk to a company’s business.
When e-health player Ping An Good Doctor was added to our Emerging Stars Equity Strategy, we began an engagement with the company to discuss ESG challenges associated with data privacy and quality control being the core material risk of the company.
To address these risks, the company has implemented data security protocols like encryption and de-identification, monitoring of system vulnerabilities, and reactive incident response. To ensure quality control, the company monitors user satisfaction and feedback on consultation services. Its AI diagnostics solutions have market-leading accuracy rates, but are used only as a complement to consultations with medical practitioners.
Throughout the Covid-19 pandemic, the company’s platform has been particularly well positioned for the rapid surge in demand for its services, and has been helpful in reducing the strain on hospitals during these difficult times. The number of new users on the platform rose nearly 900% in January 2020, over the prior month.
We feel the company demonstrates strong risk management practices across both data privacy and quality control. It is a good fit for Nordea’s Emerging Stars Equity Strategy because it can produce attractive returns while providing safe, reliable online consultations at a time when many healthcare users prefer to avoid physical hospital visits.5
In our effort to deliver returns with responsibility, we will continue to engage with companies like this to ensure they address ESG challenges and opportunities.5
How to lower the risks of Emerging Market investment
Engagement is a powerful tool for EM investors to proactively manage ESG risk and protect or enhance the value of their investments. At the heart of our responsible investment strategy is the ongoing drive to engage with the companies and the industries we have chosen to invest in. We believe this is the duty of active investors.
Our approach of regularly engaging with companies on material risk allows those in developing regions to improve their way of doing business to meet investor standards. This way they gain investment, and the ESG benefits are all positive.
NAM’s Responsible Investments Team proactively screens out companies with poor environmental records, those that don’t look after their workforce, and those in which management structures and oversight don’t meet high standards. We also have restrictions around weapons manufacturers, oil sands and coal extractors.
But we are also aware that in different cultures, with different legal frameworks, we can’t necessarily expect business practices to be in place that are identical to those in DM. In EM, there is often little disclosure in relation to material ESG risks. Therefore, before we buy a company, we need to meet, preferably face-toface, and ask questions.
Therefore, we seize many opportunities to actively engage with companies to bring about beneficial change. At NAM, our engagement efforts include working with companies to improve disclosures.
Encouragingly, we are seeing improvements in ESG disclosure. For example, Hong Kong Stock Exchange, one of Asia’s major stock exchanges, is in the process of making ESG disclosure of material issues a responsibility of boards – not just a simple box ticking exercise. In addition, insurance giant Ping An, with whom we have engaged, is building an ESG scoring system, which it will not only use itself, but will also make available to other Chinese investors. We have also worked with Ping An to address challenges around data privacy and quality control after our team identified these as core risks to the company.
Emerging Markets represent an exciting opportunity for us as we search for companies that can become ESG STARS in the future. When we identify companies that demonstrate potential, we work with them to examine areas where their ESG credentials can be improved and brought up to standard. This way they gain investment, and the ESG benefits are positive for portfolios. It’s a true win-win.
Danger in the Water: Engaging with pharma companies in India
India’s pharmaceutical industry is a major driver of the country’s economy, but it also contributes to a severe water pollution crisis—163 million people lack access to clean water. Moreover, pharmaceuticals in drinking water have been identified as a cause of antimicrobial resistance (AMR), a global threat that kills more than 700,000 people annually.
That’s why, in 2015, NAM’s Responsible Investments Team initiated a long-term engagement with pharma companies based in India that we are invested in. The team visited Hyderabad and witnessed the fierce industrial pollution surrounding pharma manufacturing sites. Consequently, we have commissioned two independent on-the-ground investigations over the past five years to understand the environmental and health impacts of pharmaceutical manufacturing.
We shared our findings with industry stakeholders and, as a result the Pharmaceutical Supply Chain Initiative (PSCI) developed an action plan. This included taking an industry approach to address pharma water pollution in India, developing a shared audit program and building the capabilities of Indian suppliers through training conferences and webinars.
As the only investor member of PSCI’s Advisory Board, NAM continues to meet regularly with pharma industry leaders to discuss progress. Most of our expectations have been met; the pharma industry has taken important steps to engage with suppliers and address water pollution. As the ongoing Coronavirus crisis emphasizes the importance of responsible action by the pharma sector and the continued need for AMR stewardship, NAM is continuing our engagement on antimicrobial resistance through the AMR Benchmark, World Water Week events and company dialogues.
Investing in our future
As the world and the market become more attuned to ESG factors, we are moving farther away from the era when investors closed their eyes to the impact a company’s actions had on the planet and people and just thought about profit. Good companies do good things in good ways because this ensures they will have a bright, long-term future. At NAM we make it our business to find those companies and help them to thrive.
NAM has developed robust ESG integration analysis and engagement practices that are particularly effective in our Emerging Stars Equity Strategy. There’s no doubt that putting ESG at the forefront of the investment case is crucial to how we deploy capital.
In the asset management industry, what is good for the planet and its inhabitants is also good for businesses and their investors. This applies to EM every bit as much as it does to DM, if not more so. Diamond miners are now nurturing herds of elephants in their very own nature reserves (De Beers), while soft-drink manufacturers focus on replenishing vulnerable water reserves (Varun). As we work to safeguard the value of assets in EM, we have discovered that it is indeed possible to deliver returns with responsibility if you have the right team in place.
The desire to make business better for the planet is at the top of the investor agenda, and surely this is something Sir David Attenborough would applaud..
1 There can be no warranty that an investment objective, targeted returns and results of an investment structure is achieved. The value of your investment can go up and down, and you could lose some or all of your invested money.
2Imogen Tew, ‘ESG to rally army of new investors’ (FTAdvisor, 21 February 2020)
3Gunnar Friede, Timo Busch and Alexander Bassen (2015) ESG and financial performance: aggregated evidence from more than 2000 empirical studies, Journal of Sustainable Finance and Investment, 5:4, 210-233, DOI: 10,1080/20430795, 2015, 1118917.
4Sustainalytics, ESG Spotlight – Emerging market equities: key sources of ESG risk, 8 August 2019.
5 There can be no warranty that an investment objective, targeted returns and results of an investment structure is achieved. The value of your investment can go up and down, and you could lose some or all of your invested money.
Nordea Asset Management is the functional name of the asset management business conducted by the legal entities Nordea Investment Funds S.A. and Nordea Investment Management AB (“the Legal Entities”) and their branches, subsidiaries and representative offices. This document is intended to provide the reader with information on Nordea’s specific capabilities. This document (or any views or opinions expressed in this document) does not amount to an investment advice nor does it constitute a recommendation to invest in any financial product, investment structure or instrument, to enter into or unwind any transaction or to participate in any particular trading strategy. This document is not an offer to buy or sell, or a solicitation of an offer to buy or sell any security or instruments or to participate to any such trading strategy. Any such offering may be made only by an Offering Memorandum, or any similar contractual arrangement. Consequently, the information contained herein will be superseded in its entirety by such Offering Memorandum or contractual arrangement in its final form. Any investment decision should therefore only be based on the final legal documentation, without limitation and if applicable, Offering Memorandum, contractual arrangement, any relevant prospectus and the latest key investor information document (where applicable) relating to the investment. The appropriateness of an investment or strategy will depend on an investor’s full circumstances and objectives. Nordea Investment Management AB recommends that investors independently evaluate particular investments and strategies as well as encourages investors to seek the advice of independent financial advisors when deemed relevant by the investor. Any products, securities, instruments or strategies discussed in this document may not be suitable for all investors. This document contains information which has been taken from a number of sources. While the information herein is considered to be correct, no representation or warranty can be given on the ultimate accuracy or completeness of such information and investors may use further sources to form a well-informed investment decision. Prospective investors or counterparties should discuss with their professional tax, legal, accounting and other adviser(s) with regards to the potential effect of any investment that they may enter into, including the possible risks and benefits of such investment. Prospective investors or counterparties should also fully understand the potential investment and ascertain that they have made an independent assessment of the appropriateness of such potential investment, based solely on their own intentions and ambitions. Investments in derivative and foreign exchange related transactions may be subject to significant fluctuations which may affect the value of an investment. Investments in Emerging Markets involve a higher element of risk. The value of the investment can greatly fluctuate and cannot be ensured. Investments in equity and debt instruments issued by banks could bear the risk of being subject to the bail-in mechanism (meaning that equity and debt instruments could be written down in order to ensure that most unsecured creditors of an institution bear appropriate losses) as foreseen in EU Directive 2014/59/EU. Nordea Asset Management has decided to bear the cost for research, i.e. such cost is covered by existing fee arrangements (Management-/Administration-Fee). Published and created by the Legal Entities adherent to Nordea Asset Management. The Legal Entities are licensed and supervised by the Financial Supervisory Authority in Sweden and Luxembourg respectively. The Legal Entities’ branches, subsidiaries and representative offices are licensed as well as regulated by their local financial supervisory authority in their respective country of domiciliation. Source (unless otherwise stated): Nordea Investment Fund S.A. Unless otherwise stated, all views expressed are those of the Legal Entities adherent to Nordea Asset Management and any of the Legal Entities’ branches, subsidiaries and representative offices. This document may not be reproduced or circulated without prior permission. Reference to companies or other investments mentioned within this document should not be construed as a recommendation to the investor to buy or sell the same but is included for the purpose of illustration. The level of tax benefits and liabilities will depend on individual circumstances and may be subject to change in the future. © The Legal Entities adherent to Nordea Asset Management and any of the Legal Entities’ branches, subsidiaries and/or representative offices.